Geretsegger 1995.
Methods | Double blind RCT. Concealment of allocation ‐ unclear. Analysis: Endpoint Active treatment: 6 weeks | |
Participants | Inclusion criteria: DSM IIIR, Major Depression and 18+ HMD, inpatient for 3 weeks +, Age: over 65 Country: Germany & Austria Setting: Inpatient | |
Interventions | Paroxetine versus amitriptyline | |
Outcomes | Side effects HMD Drop out | |
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment? | Unclear risk | B ‐ Unclear |